IP Library Granted Patent US 8,652,510
Granted Patent B2
US 8,652,510 · App. 13/953,011 · Granted Feb 18, 2014

Sterilized liquid compositions of cyanoacrylate monomer mixtures

Inventors: Sheng Zhang (Hickory, NC); Rafael Ruiz, Sr. (Hudson, NC)
Assignee: Adhezion Biomedical, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,510
App. No.
13/953,011
Granted
Feb 18, 2014
Kind
B2
Abstract

Cyanoacrylate adhesive compositions comprise a mixture of two cyanoacrylate monomers, including 2-octyl cyanoacrylate and n-butyl cyanoacrylate. The monomers are stabilized and sterilized by irradiation, and do not substantially increase in viscosity after sterilization or after two years of shelf storage. These compositions have anti-microbial properties, and may be used to close wounds as well as secure catheters inserted into the body in place.

Claims (31)

1. A cyanoacrylate adhesive composition, comprising a mixture of about 78% to about 82% by weight of monomeric 2-octyl cyanoacrylate, about 22% to about 18% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide or about 5 ppm to about 50 ppm of an acid stabilizer selected from the group consisting of sulfuric acid, phosphoric acid, and perchloric acid, wherein the composition is sterilized by Electron beam (E-beam) irradiation, wherein the viscosity of the sterilized composition over a increases by no more than about 300% over a period of at least two years of shelf storage, and wherein the composition does not contain any plasticizer.

2. The cyanoacrylate adhesive composition of claim 1 , wherein the composition comprises a mixture of about 79% to about 81% by weight of monomeric 2-octyl cyanoacrylate, about 21% to about 19% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

3. The cyanoacrylate adhesive composition of claim 1 , wherein the composition comprises a mixture of about 79% to about 81% by weight of monomeric 2-octyl cyanoacrylate, about 21% to about 19% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 8000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

4. The cyanoacrylate adhesive composition of claim 1 , wherein the composition comprises a mixture of about 80% by weight of monomeric 2-octyl cyanoacrylate, about 20% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

5. The cyanoacrylate adhesive composition of claim 1 , wherein the composition does not contain any antimicrobial agent.

6. The cyanoacrylate adhesive composition of claim 1 , wherein the composition further comprises about 10 ppm to about 150 ppm of a polymerization accelerator.

7. The cyanoacrylate adhesive composition of claim 6 , wherein the polymerization accelerator is a crown ether.

8. The cyanoacrylate adhesive composition of claim 1 , wherein the viscosity of the composition increases no more than about 200% after sterilization.

9. The cyanoacrylate adhesive composition of claim 1 , wherein the viscosity of the composition increases no more than about 250% after sterilization.

10. A method for closing a wound, comprising applying the cyanoacrylate adhesive composition of claim 1 to the wound and allowing the composition to cure over the wound, thereby closing the wound.

11. A method for securing a catheter inserted into the body of a subject, comprising applying the cyanoacrylate adhesive composition of claim 1 to a surface of the body and to a surface on the catheter and allowing the composition to cure between the surface of the body and the surface of the catheter, thereby securing the catheter in place.

12. A cyanoacrylate adhesive composition, comprising a mixture of about 78% to about 82% by weight of monomeric 2-octyl cyanoacrylate, about 22% to about 18% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide or about 5 ppm to about 50 ppm of an acid stabilizer selected from the group consisting of sulfuric acid, phosphoric acid, and perchloric acid, wherein the composition is sterilized by gamma irradiation, wherein the viscosity of the sterilized composition increases by no more than about 600% over a period of at least two years of shelf storage, and wherein the composition does not contain any plasticizer.

13. The cyanoacrylate adhesive composition of claim 12 , wherein the composition comprises a mixture of about 79% to about 81% by weight of monomeric 2-octyl cyanoacrylate, about 21% to about 19% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

14. The cyanoacrylate adhesive composition of claim 12 , wherein the composition comprises a mixture of about 79% to about 81% by weight of monomeric 2-octyl cyanoacrylate, about 21% to about 19% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 8000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

15. The cyanoacrylate adhesive composition of claim 12 , wherein the composition comprises a mixture of about 80% by weight of monomeric 2-octyl cyanoacrylate, about 20% by weight of monomeric n-butyl cyanoacrylate, about 2000 ppm to about 14,000 ppm of butylated hydroxyl anisole, and about 10 ppm to about 200 ppm of sulfur dioxide.

16. The cyanoacrylate adhesive composition of claim 12 , wherein the composition does not contain any antimicrobial agent.

17. The cyanoacrylate adhesive composition of claim 12 , wherein the composition further comprises about 10 ppm to about 150 ppm of a polymerization accelerator.

18. The cyanoacrylate adhesive composition of claim 17 , wherein the polymerization accelerator is a crown ether.

19. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 500% after sterilization.

20. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 450% after sterilization.

21. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 400% after sterilization.

22. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 350% after sterilization.

23. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 300% after sterilization.

24. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 250% after sterilization.

25. The cyanoacrylate adhesive composition of claim 12 , wherein the viscosity of the composition increases no more than about 200% after sterilization.

26. A method for closing a wound, comprising applying the cyanoacrylate adhesive composition of claim 12 to the wound and allowing the composition to cure over the wound, thereby closing the wound.

27. A method for securing a catheter inserted into the body of a subject, comprising applying the cyanoacrylate adhesive composition of claim 12 to a surface of the body and to a surface on the catheter and allowing the composition to cure between the surface of the body and the surface of the catheter, thereby securing the catheter in place.

28. The method of claim 11 , wherein the catheter is selected from the group consisting of an intravascular catheter, an epidural catheter, and an intravenous catheter.

29. The method of claim 11 , wherein the subject is a human being.

30. The method of claim 27 , wherein the catheter is selected from the group consisting of an intravascular catheter, an epidural catheter, and an intravenous catheter.

31. The method of claim 27 , wherein the subject is a human being.

Assignments (2)
CHANGE OF NAME Recorded Jul 23, 2024
From: ADHEZION BIOMEDICAL, LLC
To: H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC.
Reel/Frame 068506/0455 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2013
From: ZHANG, SHENG; RUIZ, RAFAEL, SR.
To: ADHEZION BIOMEDICAL, LLC
Reel/Frame 030987/0004 →
Continuity (3)
Continuation In Part 12378277 · Feb 12, 2009
Provisional Application 61197954 · Oct 31, 2008
Related Publication 20130310755A1 · Nov 21, 2013